{"transactions":[{"id":4621031,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":2255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":18032,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":2255},"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":4621030,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":8144,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":4621029,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":6574,"derivative":{"exercise_price":6.5223,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":4621028,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":4730,"price":24.18,"value":114371.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":35841,"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":4621027,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":2255,"price":8.63,"value":19460.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":40571,"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":4621026,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":7.51,"value":7652.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":38316,"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":4621025,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:06:23.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":6.5223,"value":5361.3306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":37297,"source":{"system":"sec-edgar","filing":"0001628280-26-062490","document":"wk-form4_1789675580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801050/000162828026062490/wk-form4_1789675580.xml","form_type":"4"}},{"id":680800,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":2255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":20287,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":2255},"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":680799,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":9163,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":680798,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":7396,"derivative":{"exercise_price":6.5223,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":680797,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":4730,"price":26.1807,"value":123834.711,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.10 to $26.25 inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":36475,"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":680796,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":2255,"price":8.63,"value":19460.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":41205,"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":680795,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":7.51,"value":7652.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":38950,"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":680794,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T20:57:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":6.5223,"value":5361.3306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":37931,"source":{"system":"sec-edgar","filing":"0001628280-26-058008","document":"wk-form4_1787173021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/wk-form4_1787173021.xml","form_type":"4"}},{"id":706302,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":2255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":22542,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":2255},"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":706301,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":10182,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":706300,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":8218,"derivative":{"exercise_price":6.5223,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":706299,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":4730,"price":26.91,"value":127284.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":37109,"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":706298,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":2255,"price":8.63,"value":19460.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":41839,"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":706297,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":7.51,"value":7652.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":39584,"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":706296,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:01:26.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":6.5223,"value":5361.3306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":38565,"source":{"system":"sec-edgar","filing":"0001628280-26-048641","document":"wk-form4_1784318483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048641/wk-form4_1784318483.xml","form_type":"4"}},{"id":733115,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":2255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":24797,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":2255},"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733114,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":11201,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733113,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":9040,"derivative":{"exercise_price":6.5223,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733112,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":635,"price":25.67,"value":16300.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":37743,"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733111,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":4096,"price":24.4093,"value":99980.4928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.095 to $24.62, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":38378,"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733110,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":2255,"price":8.63,"value":19460.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":42474,"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733109,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":1019,"price":7.51,"value":7652.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":40219,"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":733108,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T00:40:14.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":6.5223,"value":5361.3306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027."}],"balance_after":39200,"source":{"system":"sec-edgar","filing":"0001628280-26-044079","document":"wk-form4_1781743212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044079/wk-form4_1781743212.xml","form_type":"4"}},{"id":744103,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T01:21:20.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":16667,"derivative":{"exercise_price":21.23,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-26-042044","document":"wk-form4_1781054477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026042044/wk-form4_1781054477.xml","form_type":"4"}},{"id":744102,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T01:21:20.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":38378,"source":{"system":"sec-edgar","filing":"0001628280-26-042044","document":"wk-form4_1781054477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026042044/wk-form4_1781054477.xml","form_type":"4"}},{"id":791054,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T00:21:28.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":7144,"price":22.9871,"value":164219.8424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $22.79 to $23.25, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":32600,"source":{"system":"sec-edgar","filing":"0001801050-26-000002","document":"wk-form4_1778026885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105026000002/wk-form4_1778026885.xml","form_type":"4"}},{"id":815382,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:46:20.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":23.8801,"value":238801.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.61 to $24.12, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":39744,"source":{"system":"sec-edgar","filing":"0001628280-26-023736","document":"wk-form4_1775252777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026023736/wk-form4_1775252777.xml","form_type":"4"}},{"id":860505,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T21:16:29.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":25.6518,"value":256518.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.37 to $26.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":49744,"source":{"system":"sec-edgar","filing":"0001628280-26-014639","document":"wk-form4_1772658986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026014639/wk-form4_1772658986.xml","form_type":"4"}},{"id":918862,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-05T00:23:03.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":25.0483,"value":250483.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.61 to $25.60, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":59744,"source":{"system":"sec-edgar","filing":"0001628280-26-005567","document":"wk-form4_1770250980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026005567/wk-form4_1770250980.xml","form_type":"4"}},{"id":945523,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:31:57.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":28.9606,"value":289606.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.905 to $29.17, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":69744,"source":{"system":"sec-edgar","filing":"0001628280-26-000969","document":"wk-form4_1767738714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026000969/wk-form4_1767738714.xml","form_type":"4"}},{"id":980967,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:23:40.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":30.2133,"value":302133.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $29.85 to $30.5650, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":79744,"source":{"system":"sec-edgar","filing":"0001801050-25-000008","document":"wk-form4_1764800618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105025000008/wk-form4_1764800618.xml","form_type":"4"}},{"id":1006529,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T23:24:11.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":25.2669,"value":252669.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.10 to $25.4298, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":89744,"source":{"system":"sec-edgar","filing":"0001801050-25-000007","document":"wk-form4_1762385048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105025000007/wk-form4_1762385048.xml","form_type":"4"}},{"id":1023941,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-03T21:01:57.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":9538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":9538},"source":{"system":"sec-edgar","filing":"0001801050-25-000005","document":"wk-form4_1759525315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105025000005/wk-form4_1759525315.xml","form_type":"4"}},{"id":1023940,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T21:01:57.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":462,"price":18.9227,"value":8742.2874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $18.84 to $19.038, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":99744,"source":{"system":"sec-edgar","filing":"0001801050-25-000005","document":"wk-form4_1759525315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105025000005/wk-form4_1759525315.xml","form_type":"4"}},{"id":1023939,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T21:01:57.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":9538,"price":18.9227,"value":180484.7126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $18.84 to $19.038, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":100206,"source":{"system":"sec-edgar","filing":"0001801050-25-000005","document":"wk-form4_1759525315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105025000005/wk-form4_1759525315.xml","form_type":"4"}},{"id":1023938,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T21:01:57.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":9538,"price":1.6806,"value":16029.5628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."}],"balance_after":109744,"source":{"system":"sec-edgar","filing":"0001801050-25-000005","document":"wk-form4_1759525315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000180105025000005/wk-form4_1759525315.xml","form_type":"4"}},{"id":1047449,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-04T22:41:03.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001787306-25-000132","document":"wk-form4_1757025659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000132/wk-form4_1757025659.xml","form_type":"4"}},{"id":1047448,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T22:41:03.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":15.6383,"value":156383.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.45 to $15.81, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":100206,"source":{"system":"sec-edgar","filing":"0001787306-25-000132","document":"wk-form4_1757025659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000132/wk-form4_1757025659.xml","form_type":"4"}},{"id":1047447,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T22:41:03.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."}],"balance_after":110206,"source":{"system":"sec-edgar","filing":"0001787306-25-000132","document":"wk-form4_1757025659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000132/wk-form4_1757025659.xml","form_type":"4"}},{"id":1073851,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-05T22:28:38.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":false,"shares":3890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":3890},"source":{"system":"sec-edgar","filing":"0001787306-25-000115","document":"wk-form4_1754432914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000115/wk-form4_1754432914.xml","form_type":"4"}},{"id":1073850,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-05T22:28:38.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":false,"shares":6110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.5802,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":6110},"source":{"system":"sec-edgar","filing":"0001787306-25-000115","document":"wk-form4_1754432914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000115/wk-form4_1754432914.xml","form_type":"4"}},{"id":1073849,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T22:28:38.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":3890,"price":14.2982,"value":55619.998,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.14 to $14.55, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":100206,"source":{"system":"sec-edgar","filing":"0001787306-25-000115","document":"wk-form4_1754432914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000115/wk-form4_1754432914.xml","form_type":"4"}},{"id":1073848,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T22:28:38.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":true,"shares":3890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."}],"balance_after":104096,"source":{"system":"sec-edgar","filing":"0001787306-25-000115","document":"wk-form4_1754432914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000115/wk-form4_1754432914.xml","form_type":"4"}},{"id":1073847,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T22:28:38.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":6110,"price":14.2982,"value":87362.002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.14 to $14.55, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":100206,"source":{"system":"sec-edgar","filing":"0001787306-25-000115","document":"wk-form4_1754432914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000115/wk-form4_1754432914.xml","form_type":"4"}},{"id":1073846,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T22:28:38.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":true,"shares":6110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."}],"balance_after":106316,"source":{"system":"sec-edgar","filing":"0001787306-25-000115","document":"wk-form4_1754432914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000115/wk-form4_1754432914.xml","form_type":"4"}},{"id":1094053,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:25:34.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":9208,"price":13.8391,"value":127430.4328,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.65 to $13.99, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":100206,"source":{"system":"sec-edgar","filing":"0001787306-25-000101","document":"wk-form4_1751487930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000101/wk-form4_1751487930.xml","form_type":"4"}},{"id":1104532,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:32:21.000Z","date":"2025-06-18","kind":"sale","planned":true,"acquired":false,"shares":10139,"price":13.3715,"value":135573.6385,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.2118 to $13.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":109414,"source":{"system":"sec-edgar","filing":"0001787306-25-000099","document":"wk-form4_1750451534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000099/wk-form4_1750451534.xml","form_type":"4"}},{"id":1109346,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T00:17:58.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":20568,"derivative":{"exercise_price":13.5,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":20568},"source":{"system":"sec-edgar","filing":"0002065881-25-000028","document":"wk-form4_1750119471.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000028/wk-form4_1750119471.xml","form_type":"4"}},{"id":1109345,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T00:17:58.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":119553,"source":{"system":"sec-edgar","filing":"0002065881-25-000028","document":"wk-form4_1750119471.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000028/wk-form4_1750119471.xml","form_type":"4"}},{"id":1158546,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:49:35.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":14.6357,"value":146357.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 5, 2024, by the Reporting Person, with a plan end date of May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.19 to $14.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":111944,"source":{"system":"sec-edgar","filing":"0001787306-25-000077","document":"wk-form4_1746478168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000077/wk-form4_1746478168.xml","form_type":"4"}},{"id":1178600,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:21:21.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":15.1236,"value":151236.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 5, 2024, by the Reporting Person, with a plan end date of May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.83 to $15.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":121944,"source":{"system":"sec-edgar","filing":"0001787306-25-000054","document":"wk-form4_1743711673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000054/wk-form4_1743711673.xml","form_type":"4"}},{"id":1225831,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T00:43:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":13.0048,"value":130048.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 5, 2024, by the Reporting Person, with a plan end date of May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.68 to $13.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":131944,"source":{"system":"sec-edgar","filing":"0001787306-25-000040","document":"wk-form4_1741135403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000040/wk-form4_1741135403.xml","form_type":"4"}},{"id":1283446,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-05T01:00:59.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":12.71,"value":127100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 5, 2024, by the Reporting Person, with a plan end date of May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.56 to $13.02, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":141944,"source":{"system":"sec-edgar","filing":"0001787306-25-000015","document":"wk-form4_1738717253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000015/wk-form4_1738717253.xml","form_type":"4"}},{"id":1309524,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:08:13.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":14.6714,"value":146714.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 5, 2024, by the Reporting Person, with a plan end date of May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.16 to $15.11, inclusive. The Reporting Person hereby\nundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective\nprice within the range set forth in this footnote."}],"balance_after":151944,"source":{"system":"sec-edgar","filing":"0001787306-25-000002","document":"wk-form4_1736197683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000002/wk-form4_1736197683.xml","form_type":"4"}},{"id":1344265,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T21:16:47.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":12.5133,"value":125133.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 5, 2024, by the Reporting Person, with a plan end date of May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.37 to $13.00, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":161944,"source":{"system":"sec-edgar","filing":"0001787306-24-000167","document":"wk-form4_1733260600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000167/wk-form4_1733260600.xml","form_type":"4"}},{"id":1374913,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:46:02.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":8.6541,"value":86541.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.4493 to $8.82, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":171944,"source":{"system":"sec-edgar","filing":"0001787306-24-000143","document":"wk-form4_1730843155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000143/wk-form4_1730843155.xml","form_type":"4"}},{"id":1391333,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-03T20:55:44.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":9.2616,"value":92616.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.22 to $9.4138, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":181944,"source":{"system":"sec-edgar","filing":"0001787306-24-000137","document":"wk-form4_1727988938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000137/wk-form4_1727988938.xml","form_type":"4"}},{"id":1413443,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T21:56:27.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":10.7695,"value":107695.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.67 to $10.865, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total  shares reported in Column 5 includes shares held in a revocable living trust that previously were reported indirectly."}],"balance_after":191944,"source":{"system":"sec-edgar","filing":"0001787306-24-000131","document":"wk-form4_1725573381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000131/wk-form4_1725573381.xml","form_type":"4"}},{"id":1440323,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-05T20:37:03.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":6614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":6614},"source":{"system":"sec-edgar","filing":"0001787306-24-000115","document":"wk-form4_1722890217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000115/wk-form4_1722890217.xml","form_type":"4"}},{"id":1440322,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:37:03.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":3386,"price":9.8696,"value":33418.4656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.76 to $10.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":176953,"source":{"system":"sec-edgar","filing":"0001787306-24-000115","document":"wk-form4_1722890217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000115/wk-form4_1722890217.xml","form_type":"4"}},{"id":1440321,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:37:03.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":6614,"price":9.8696,"value":65277.5344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.76 to $10.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":180339,"source":{"system":"sec-edgar","filing":"0001787306-24-000115","document":"wk-form4_1722890217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000115/wk-form4_1722890217.xml","form_type":"4"}},{"id":1440320,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:37:03.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":6614,"price":1.6806,"value":11115.4884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":186953,"source":{"system":"sec-edgar","filing":"0001787306-24-000115","document":"wk-form4_1722890217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000115/wk-form4_1722890217.xml","form_type":"4"}},{"id":1461983,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-02T23:13:16.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":4319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":6614,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":4319},"source":{"system":"sec-edgar","filing":"0001787306-24-000108","document":"wk-form4_1719961990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000108/wk-form4_1719961990.xml","form_type":"4"}},{"id":1461982,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-02T23:13:16.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":5681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":5681},"source":{"system":"sec-edgar","filing":"0001787306-24-000108","document":"wk-form4_1719961990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000108/wk-form4_1719961990.xml","form_type":"4"}},{"id":1461981,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T23:13:16.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":9.3141,"value":93141.0,"ownership":{"direct":true},"balance_after":180339,"source":{"system":"sec-edgar","filing":"0001787306-24-000108","document":"wk-form4_1719961990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000108/wk-form4_1719961990.xml","form_type":"4"}},{"id":1461980,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T23:13:16.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":4319,"price":1.6806,"value":7258.5114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":190339,"source":{"system":"sec-edgar","filing":"0001787306-24-000108","document":"wk-form4_1719961990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000108/wk-form4_1719961990.xml","form_type":"4"}},{"id":1461979,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T23:13:16.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":5681,"price":1.6806,"value":9547.4886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":186020,"source":{"system":"sec-edgar","filing":"0001787306-24-000108","document":"wk-form4_1719961990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000108/wk-form4_1719961990.xml","form_type":"4"}},{"id":1474352,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:52:25.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":27052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":27052,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":27052},"source":{"system":"sec-edgar","filing":"0001787306-24-000105","document":"wk-form4_1718743938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000105/wk-form4_1718743938.xml","form_type":"4"}},{"id":1474351,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:52:25.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":10139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.  The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":180339,"source":{"system":"sec-edgar","filing":"0001787306-24-000105","document":"wk-form4_1718743938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000105/wk-form4_1718743938.xml","form_type":"4"}},{"id":1488001,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-06T20:15:39.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":6458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":6458},"source":{"system":"sec-edgar","filing":"0001787306-24-000087","document":"wk-form4_1717704925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000087/wk-form4_1717704925.xml","form_type":"4"}},{"id":1488000,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-06T20:15:39.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":5681,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001787306-24-000087","document":"wk-form4_1717704925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000087/wk-form4_1717704925.xml","form_type":"4"}},{"id":1487999,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:15:39.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":6458,"price":8.0142,"value":51755.7036,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $8.00 to $8.155, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":170200,"source":{"system":"sec-edgar","filing":"0001787306-24-000087","document":"wk-form4_1717704925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000087/wk-form4_1717704925.xml","form_type":"4"}},{"id":1487998,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:15:39.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":3542,"price":8,"value":28336.0,"ownership":{"direct":true},"balance_after":176658,"source":{"system":"sec-edgar","filing":"0001787306-24-000087","document":"wk-form4_1717704925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000087/wk-form4_1717704925.xml","form_type":"4"}},{"id":1487997,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:15:39.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":6458,"price":1.6806,"value":10853.3148,"ownership":{"direct":true},"balance_after":180200,"source":{"system":"sec-edgar","filing":"0001787306-24-000087","document":"wk-form4_1717704925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000087/wk-form4_1717704925.xml","form_type":"4"}},{"id":1487996,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:15:39.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":3542,"price":1.6806,"value":5952.6852,"ownership":{"direct":true},"balance_after":173742,"source":{"system":"sec-edgar","filing":"0001787306-24-000087","document":"wk-form4_1717704925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000087/wk-form4_1717704925.xml","form_type":"4"}},{"id":1868926,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T22:54:36.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":12220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023."}],"balance_after":12220,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":12220},"source":{"system":"sec-edgar","filing":"0001787306-23-000050","document":"wk-form4_1685746466.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000050/wk-form4_1685746466.xml","form_type":"4"}},{"id":1868925,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:54:36.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":170200,"source":{"system":"sec-edgar","filing":"0001787306-23-000050","document":"wk-form4_1685746466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000050/wk-form4_1685746466.xml","form_type":"4"}},{"id":1917777,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-18T23:00:44.000Z","date":"2023-04-17","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":6458,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001787306-23-000036","document":"wf-form4_168185882846729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000036/wf-form4_168185882846729.xml","form_type":"4"}},{"id":1917776,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T23:00:44.000Z","date":"2023-04-17","kind":"sale","planned":true,"acquired":false,"shares":8500,"price":13.968,"value":118728.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.76 to $14.20, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":165825,"source":{"system":"sec-edgar","filing":"0001787306-23-000036","document":"wf-form4_168185882846729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000036/wf-form4_168185882846729.xml","form_type":"4"}},{"id":1917775,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T23:00:44.000Z","date":"2023-04-17","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":1.6806,"value":14285.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":174325,"source":{"system":"sec-edgar","filing":"0001787306-23-000036","document":"wf-form4_168185882846729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000036/wf-form4_168185882846729.xml","form_type":"4"}},{"id":1922131,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-10T20:13:14.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":14958,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001787306-23-000027","document":"wf-form4_168115758269324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000027/wf-form4_168115758269324.xml","form_type":"4"}},{"id":1922130,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-10T20:13:14.000Z","date":"2023-04-06","kind":"sale","planned":true,"acquired":false,"shares":8500,"price":12.01,"value":102085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.035, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":165825,"source":{"system":"sec-edgar","filing":"0001787306-23-000027","document":"wf-form4_168115758269324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000027/wf-form4_168115758269324.xml","form_type":"4"}},{"id":1922129,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-10T20:13:14.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":1.6806,"value":14285.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":174325,"source":{"system":"sec-edgar","filing":"0001787306-23-000027","document":"wf-form4_168115758269324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000027/wf-form4_168115758269324.xml","form_type":"4"}},{"id":2002754,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-21T12:20:56.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":23458,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001787306-23-000010","document":"wf-form4_167698204256036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000010/wf-form4_167698204256036.xml","form_type":"4"}},{"id":2002753,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-21T12:20:56.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":8500,"price":16.9826,"value":144352.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $16.84 to $17.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":165825,"source":{"system":"sec-edgar","filing":"0001787306-23-000010","document":"wf-form4_167698204256036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000010/wf-form4_167698204256036.xml","form_type":"4"}},{"id":2002752,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-21T12:20:56.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":8500,"price":1.6806,"value":14285.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":174325,"source":{"system":"sec-edgar","filing":"0001787306-23-000010","document":"wf-form4_167698204256036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000010/wf-form4_167698204256036.xml","form_type":"4"}},{"id":2051956,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-19T01:18:25.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":31958,"derivative":{"exercise_price":1.68,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001787306-23-000004","document":"wf-form4_167409108112700.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000004/wf-form4_167409108112700.xml","form_type":"4"}},{"id":2051955,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T01:18:25.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":8500,"price":13.7241,"value":116654.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":165825,"source":{"system":"sec-edgar","filing":"0001787306-23-000004","document":"wf-form4_167409108112700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000004/wf-form4_167409108112700.xml","form_type":"4"}},{"id":2051954,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T01:18:25.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":8500,"price":1.68,"value":14280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":174325,"source":{"system":"sec-edgar","filing":"0001787306-23-000004","document":"wf-form4_167409108112700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000004/wf-form4_167409108112700.xml","form_type":"4"}},{"id":2111448,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-17T21:29:57.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":1020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":40458,"derivative":{"exercise_price":1.68,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":1020},"source":{"system":"sec-edgar","filing":"0001787306-22-000075","document":"wf-form4_166872057856154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730622000075/wf-form4_166872057856154.xml","form_type":"4"}},{"id":2111447,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T21:29:57.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":3403,"price":20.0125,"value":68102.5375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,812 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":165825,"source":{"system":"sec-edgar","filing":"0001787306-22-000075","document":"wf-form4_166872057856154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730622000075/wf-form4_166872057856154.xml","form_type":"4"}},{"id":2111446,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T21:29:57.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":1020,"price":1.68,"value":1713.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,812 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":169228,"source":{"system":"sec-edgar","filing":"0001787306-22-000075","document":"wf-form4_166872057856154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730622000075/wf-form4_166872057856154.xml","form_type":"4"}},{"id":2140941,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-06T20:26:23.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":6000,"price":20.2944,"value":121766.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $20.06 to $20.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,812 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":168208,"source":{"system":"sec-edgar","filing":"0001567619-22-018322","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000156761922018322/doc1.xml","form_type":"4"}},{"id":2180559,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":21493,"kind":"person","name":"Welgus Howard G.","position":1,"cik":"0001801050","reported_name":"Welgus Howard G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T21:06:57.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":6000,"price":24.7981,"value":148788.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $24.51 to $25.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,812 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":174208,"source":{"system":"sec-edgar","filing":"0001567619-22-016413","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000156761922016413/doc1.xml","form_type":"4"}}],"next_cursor":"2022-08-17T21:06:57.000000Z,2180559"}